Sooma Oy is a Finnish medical device company developing non-invasive brain stimulation devices for treatment of neurological and psychiatric disorders. Since its establishment in 2013, Sooma has been working closely with leading experts in psychiatry and clinical neurophysiology to provide better care for all of us.

Sooma tDCS, a low threshold therapy solution for major depressive disorder, was launched at the end of 2014. The treatment is safe, effective, well tolerated and suitable for most people.


Our products are designed and manufactured using internationally-accepted standards of performance. Sooma Oy is ISO 13485 certified (medical device standard).

In the EU, our products are CE-marked as medical devices according to the Medical device directive 93/42/EEC. Our manufacturing is located in Finland.

All Sooma products are CE-marked as medical devices or medical device accessories. Medical device CE-marking ensures that the products are safe to use in patient work and also effective within their indication of use.

Please contact us if you wish to know more about Sooma quality.

Our promise to you

Sooma Ltd is committed to provide neurological therapy devices and services that meet customer and regulatory requirements by maintaining an effective quality management system. We at Sooma are maintaining and continuously improving our quality system by managing all product related risks and achieving objectives related to:

Customer satisfaction

Product development

Quality system planning and improvement

Supplier quality assurance

Personnel training and competence

Regulatory compliance and internal/external audits

Process effectiveness and efficiency